Financial Statement Analysis

Topics: Generally Accepted Accounting Principles, Balance sheet, Asset Pages: 28 (5310 words) Published: November 5, 2014
FINANCIAL STATEMENT ANALYSIS PROJECT

Presented By
Group Leader:

Table of contents: -

1.SECTION 1: EXECUTIVE SUMMARY ………………………….…. 2 2.SECTION 2: BALANCE SHEET ANALYSIS ……………………………….. 4 3.SECTION 3: INCOME STATEMENT…………………………………………17 4.SECTION 4: RATIO ANALYSIS………………………………………………27 5.SECTION 5: CONCLUSIONS/RECOMMENDATIONS……………….…......30 6.SECTION 6: PUBLIC PERCEPTION AND RECENT RESULTS………….…31 7. APPENDIX 38

Date:-03/08/14

SECTION 1: EXECUTIVE SUMMARY

ABBOTT LABORATORIES: -

Official name of the corporation : - Abbott Laboratories (ABT) •Location of the corporate headquarters: - 100 Abbott Park Road •Abbott Park, Illinois 60064-6400, US
The state in which the company is incorporated: - Illinois, U.S. •Company Internet address: - http://www.abbott.com
Stock symbol of the corporation and the exchange on which it is traded: - ABT •Fiscal year-end of the corporation: - January 1st to December 31st •Date of the 10-K filing according to the financial statements provided: - February 21st 2014 •The company’s independent accountant/auditor: - Principle Accountant: Mr. Robert E. Funck, Auditor: Deloitte & Touche LLP (Deloitte) •The primary products(s) and/or services (s) of the corporation:- •Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott's* principal business is the discovery, development, manufacture, and sale of a broad and diversified line of health care products.

Abbott has four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Details of each segment are as follow:

Established Pharmaceutical Products:
These products include a broad line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States, and are generally sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses, depending on the market served.

Principle product includes: Gastroenterology products, women's health products, cardiovascular and metabolic products, pain and central nervous system products, respiratory drugs and vaccines.

Diagnostic Products:
These products include a broad line of diagnostic systems and tests manufactured, marketed, and sold worldwide to blood banks, hospitals, commercial laboratories, clinics, physicians' offices, government agencies, alternate-care testing sites, and plasma protein therapeutic companies.

Principle product includes: Immunoassay and clinical chemistry systems, Assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological diseases, and infectious diseases, a full line of hematology systems, The m2000™, an instrument that automates the extraction, purification, and preparation of DNA and RNA, informatics and automation solutions, the i-STAT® point-of-care diagnostic systems and tests for blood analysis.

Nutritional Products:
These products include a broad line of pediatric and adult nutritional products manufactured, marketed, and sold worldwide.

Principle product includes: Various forms of prepared infant formula and follow-on formula, Adult and other pediatric nutritional products, Nutritional products used in enteral feeding in health care institutions, Zone Perfect® bars and the EAS® family of nutritional brands.

Vascular Products:
These products include a broad line of coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease manufactured, marketed and sold worldwide. Principle product includes: Xience Xpedition, Absorb™, Multi-Link 8®, TREK®

ACADIA PHARMACEUTICALS INC.: -

Official name of the corporation : - ACADIA PHARMACEUTICALS INC (ACAD) •Location of the corporate...
Continue Reading

Please join StudyMode to read the full document

You May Also Find These Documents Helpful

  • Essay on To What Extent Might the Cash Flow Statement Help to Overcome the Traditional Limitations of Financial Statement Analysis in...
  • Essay about ACCT5930 FINANCIAL ACCOUNTING
  • Financial Statement Analysis Paper
  • Hexaware Technologies
  • Financial Statement Analysis Essay
  • Comparative Analysis of Neepco Through Ratio Analysisgh Ratio Analy Essay
  • Financial Statement Analysis Handout 2015 Research Paper
  • A Financial Statement Analysis Project for Introductory Financial Accounting Essay

Become a StudyMode Member

Sign Up - It's Free